Determination of phenylephrine in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 915-916, Issue , 2013, Pages 28-32

  Feng, Sheng ^a   Zhao, Qian ^a   Jiang, Ji ^a   Hu, Pei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Determination; Human plasma; Phenylephrine; UPLC MS MS

Indexed keywords

AMMONIUM FORMATE; CHROMATOGRAPHIC SEPARATIONS; CONCENTRATION RANGES; DETERMINATION; EXTRACTION RECOVERY; HUMAN PLASMAS; ISOCRATIC CONDITIONS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LOWER LIMIT OF QUANTIFICATIONS; MATRIX EFFECTS; MULTIPLE-REACTION MONITORING MODES; PHARMACOKINETIC STUDIES; PHENYLEPHRINE; PHENYLEPHRINE HYDROCHLORIDE; PLASMA SAMPLES; POSITIVE ELECTROSPRAY IONIZATION; RAPID METHOD; SOLID-PHASE EXTRACTION; ULTRAPERFORMANCE LIQUID CHROMATOGRAPHY; UPLC-MS/MS;

ACETONITRILE; AMMONIUM COMPOUNDS; CHROMATOGRAPHY; ELECTROSPRAY IONIZATION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

PLASMA (HUMAN);

ACETONITRILE; AMMONIUM FORMATE; PHENYLEPHRINE;

ACCURACY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; ELECTROSPRAY MASS SPECTROMETRY; FLOW RATE; HUMAN; LIMIT OF QUANTITATION; PH; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ACETONITRILES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; FORMATES; HUMANS; LEAST-SQUARES ANALYSIS; PHENYLEPHRINE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 84872399741     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.12.019     Document Type: Article

References (17)

1. Hatton R.C., Winterstein A.G., McKelvey R.P., Shuster J., Hendeles L. Ann. Pharmacother. 2007, 41:381.
2. Desjardins P.J., Berlin R.G. Br. J. Clin. Pharmacol. 2007, 64:555.
3. Vuma V., Kanfer I. J. Chromatogr. B 1996, 678:245.
4. Gumbhir K., Mason W.D. J. Pharm. Biomed. Anal. 1996, 14:623.
5. Ptacek P., Klima J., Macek J. J. Chromatogr. B 2007, 858:263.
6. Churchwell M.I., Twaddle N.C., Meeker L.R., Doerge D.R. J. Chromatogr. B 2005, 825:134.
7. Batt A.L., Kostich M.S., Lazorchak J.M. Anal. Chem. 2008, 80:5021.
8. Mensch J., Noppe M., Adriaensen J., Melis A., Mackie C., Augustijns P., Brewster M.E. J. Chromatogr. B 2007, 847:182.
9. Waterval W.A., Scheijen J.L.J.M., Ortmans-Ploemen M.M.J.C., Habets-van der Poel C.D., Bierau J. Clin. Chim. Acta 2009, 407:36.
10. Berg T., Lundanes E., Christophersen A.S., Strand D.H. J. Chromatogr. B 2009, 877:421.
11. Understanding Phenylephrine Metabolism, 2007, Pharmacokinetics, Bioavailability and Activity. http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4335b1-01-Schering-Plough.pdf.
12. Stokvis E., Rosing H., Beijnen J.H. Rapid Commun. Mass Spectrom. 2005, 19:401.
13. Guidance for Industry Bioanalytical Method Validation, 2001. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
14. State Food and Drug Administration, 2005. http://www.sda.gov.cn/gsz05106/07.pdf.
15. Taylor P.J. Clin. Biochem. 2005, 38:328.
16. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:30.
17. Matuszewski B.K. J. Chromatogr. B 2006, 830:293.